190 related articles for article (PubMed ID: 18690648)
1. Disialoganglioside GD3 synthase expression recruits membrane transglutaminase 2 during erythroid differentiation of the human chronic myelogenous leukemia K562 cells.
Kang SK; Kim YS; Kong YJ; Song KH; Chang YC; Park YG; Ko JH; Lee YC; Kim CH
Proteomics; 2008 Aug; 8(16):3317-28. PubMed ID: 18690648
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
3. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
5. Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells.
Ha SH; Kang SK; Choi H; Kwak CH; Abekura F; Park JY; Kwon KM; Chang HW; Lee YC; Ha KT; Hou BK; Chung TW; Kim CH
Oncotarget; 2017 Sep; 8(42):72205-72219. PubMed ID: 29069780
[TBL] [Abstract][Full Text] [Related]
6. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
7. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
Huang HM; Liu JC
J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
[TBL] [Abstract][Full Text] [Related]
8. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
Ko K; Furukawa K; Takahashi T; Urano T; Sanai Y; Nagino M; Nimura Y; Furukawa K
Oncogene; 2006 Nov; 25(52):6924-35. PubMed ID: 16862187
[TBL] [Abstract][Full Text] [Related]
9. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B
Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Bcr-Abl function leads to erythroid differentiation of K562 cells via downregulation of ERK.
Brózik A; Casey NP; Hegedus C; Bors A; Kozma A; Andrikovics H; Geiszt M; Német K; Magócsi M
Ann N Y Acad Sci; 2006 Dec; 1090():344-54. PubMed ID: 17384279
[TBL] [Abstract][Full Text] [Related]
11. Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid.
Aoki S; Kong D; Matsui K; Kobayashi M
Anticancer Res; 2004; 24(4):2325-30. PubMed ID: 15330179
[TBL] [Abstract][Full Text] [Related]
12. High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I.
Okada M; Furukawa K; Yamashiro S; Yamada Y; Haraguchi M; Horibe K; Kato K; Tsuji Y; Furukawa K
Cancer Res; 1996 Jun; 56(12):2844-8. PubMed ID: 8665524
[TBL] [Abstract][Full Text] [Related]
13. [Cyclin D2 expression in chronic myelogenous leukemia].
Song JM; Xu D; Fan EJ; Xu SR; Li D; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):103-5. PubMed ID: 14990053
[TBL] [Abstract][Full Text] [Related]
14. Parallel regulation of PKC-alpha and PKC-delta characterizes the occurrence of erythroid differentiation from human primary hematopoietic progenitors.
Lanuti P; Bertagnolo V; Gaspari AR; Ciccocioppo F; Pierdomenico L; Bascelli A; Sabatino G; Miscia S; Marchisio M
Exp Hematol; 2006 Dec; 34(12):1624-34. PubMed ID: 17157158
[TBL] [Abstract][Full Text] [Related]
15. Membrane type sialidase inhibits the megakaryocytic differentiation of human leukemia K562 cells.
Jin UH; Ha KT; Kim KW; Chang YC; Lee YC; Ko JH; Kim CH
Biochim Biophys Acta; 2008 May; 1780(5):757-63. PubMed ID: 18339327
[TBL] [Abstract][Full Text] [Related]
16. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
17. Differentiation in chronic myelogenous leukemia cell K562 by spongean sesterterpene.
Aoki S; Higuchi K; Isozumi N; Matsui K; Miyamoto Y; Itoh N; Tanaka K; Kobayashi M
Biochem Biophys Res Commun; 2001 Mar; 282(2):426-31. PubMed ID: 11401476
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562.
Yin DD; Fan FY; Hu XB; Hou LH; Zhang XP; Liu L; Liang YM; Han H
Leuk Res; 2009 Jan; 33(1):109-14. PubMed ID: 18687467
[TBL] [Abstract][Full Text] [Related]
19. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
Cell Growth Differ; 1997 Mar; 8(3):319-26. PubMed ID: 9056674
[TBL] [Abstract][Full Text] [Related]
20. Disialoganglioside GD3 increases in the secretion of apoB-containing lipoproteins.
Kang SK; Jin UH; Kim KW; Lee YC; Park YG; Kim CH
Biochem Biophys Res Commun; 2007 May; 356(2):418-23. PubMed ID: 17368571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
